# Bliss GVS Pharma Ltd (BLISSGVS)
> Exchange: NSE | Sector: Pharma | ISIN: INE416D01022

## Price
Current Price: ₹300.35
Day Change: +1.74%
52W High: ₹293
52W Low: ₹118
Market Cap: ₹3,040 Cr

## Valuation
P/E: 28.2
P/B: 2.68
EPS: ₹10.19
Book Value: ₹107.21
Dividend Yield: 0%

## Returns
1Y Return: 72.81%

## Profitability
ROE: 0%
ROCE: 9.39%
Debt/Equity: 0.04
Revenue Growth: 3.7%
Profit Growth: -5.7%
EBITDA Margin: 15.41%
Operating Margin: 12.11%

## About
Bliss GVS Pharma Ltd is a Drug Manufacturers - Specialty & Generic company listed on NSE. The page combines exchange quotes, financial statements, shareholding, filings, and news so investors can review the business in one place.
Sector: Pharma
Industry: Drug Manufacturers - Specialty & Generic
Sub Industry: Unknown

## Business Model
Overview: Bliss GVS Pharma Ltd makes money through Domestic formulations, Exports and regulated markets, Specialty or institutional sales in Drug Manufacturers - Specialty & Generic. Revenue quality depends on demand growth, margin discipline, balance-sheet strength, and the company's ability to defend its position within Pharma.
Source: Derived from stock data
Revenue Streams:
- Domestic formulations
- Exports and regulated markets
- Specialty or institutional sales
Operating Model:
- Develops, manufactures, distributes, or services healthcare products across regulated channels.
- Approvals, product mix, compliance quality, and R&D productivity shape growth.
Recent Context:
- Announcement: Announcement under Regulation 30 (LODR)-Newspaper Publication
- Announcement: Announcement under Regulation 30 (LODR)-Change in Management
- BSE Filing: Announcement under Regulation 30 (LODR)-Newspaper Publication

## Access
Current tier: anonymous
More history: Register free to see 8 more years.

## Data Freshness
Quote Updated: 2026-05-24T20:00:00.755Z
Price History Updated: 2026-05-17T21:25:01.054Z
Latest Price History Date: 2026-05-17
Technicals Updated: 2026-05-17T21:25:01.054Z
Quant Updated: 2026-05-17T21:25:01.054Z
Sentiment Updated: 2026-05-17T21:25:01.054Z
Financials Status: current
Financials Updated: 2026-05-18T15:31:28.953Z
Financials Last Attempt: 2026-05-18T15:31:28.953Z
Financials Provider Tried: yahoo
Latest P&L Period: FY25
Latest Balance Sheet Period: FY25
Latest Cash Flow Period: FY25

## P&L (Mar 2016)
Revenue: ₹407 Cr
Operating Profit: ₹103 Cr (OPM 25%)
Net Profit: ₹61 Cr
Tax: ₹96 Cr

## Annual P&L History
Mar 2016: Rev ₹407Cr | PAT ₹61Cr | OPM 25%
Mar 2017: Rev ₹547Cr | PAT ₹100Cr | OPM 29%
Mar 2018: Rev ₹798Cr | PAT ₹113Cr | OPM 25%

## Balance Sheet (Mar 2016)
Total Assets: ₹662 Cr
Total Liabilities: ₹662 Cr
Borrowings: ₹160 Cr
Cash: ₹undefined Cr

## Shareholding
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%

## Board
- Shibroor Narsimha Kamath, Chief Executive Officer
- Deepak B. Sawant, Chief Financial Officer
- Prashant  Churi, Vice President of Technical Operations
- Aditi Himanshu Bhatt, Compliance Officer, Company Secretary & Nodal Officer
- Shreekrushna  Joshi, Head of Legal

---
Source: rupiya.io/stocks/blissgvs
Disclaimer: For research and education only. Not investment advice.